Evidence map›Paper›PMID 33182534›Full record

ArticleMolecules (Basel, Switzerland)2020

A Molecularly Imprinted Polymer-based Dye Displacement Assay for the Rapid Visual Detection of Amphetamine in Urine.

Joseph W Lowdon, Kasper Eersels, Rocio Arreguin-Campos, Manlio Caldara, Benjamin Heidt, Renato Rogosic, Kathia L Jimenez-Monroy, Thomas J Cleij, Hanne Diliën, Bart van Grinsven

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Joseph W LowdonSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0002-6182-7007
Kasper EerselsSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0002-0214-1320
Rocio Arreguin-CamposSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.
Manlio CaldaraSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.
Benjamin HeidtSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0003-1629-3146
Renato RogosicSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.
Kathia L Jimenez-MonroySensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.
Thomas J CleijSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0003-0172-9330
Hanne DiliënSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0001-5409-3941
Bart van GrinsvenSensor Engineering Group, Faculty of Science and Engineering, Maastricht University, PO Box 616, 6200 MD Maastricht, The Netherlands.ORCID 0000-0002-6939-0866
Maastricht University · NL

Funding

Province of Limburg Limburg Meet
6 · The paper itself

Abstract

The rapid sensing of drug compounds has traditionally relied on antibodies, enzymes and electrochemical reactions. These technologies can frequently produce false positives/negatives and require specific conditions to operate. Akin to antibodies, molecularly imprinted polymers (MIPs) are a more robust synthetic alternative with the ability to bind a target molecule with an affinity comparable to that of its natural counterparts. With this in mind, the research presented in this article introduces a facile MIP-based dye displacement assay for the detection of (±) amphetamine in urine. The selective nature of MIPs coupled with a displaceable dye enables the resulting low-cost assay to rapidly produce a clear visual confirmation of a target's presence, offering huge commercial potential. The following manuscript characterizes the proposed assay, drawing attention to various facets of the sensor design and optimization. To this end, synthesis of a MIP tailored towards amphetamine is described, scrutinizing the composition and selectivity (ibuprofen, naproxen, 2-methoxphenidine, quetiapine) of the reported synthetic receptor. Dye selection for the development of the displacement assay follows, proceeded by optimization of the displacement process by investigating the time taken and the amount of MIP powder required for optimum displacement. An optimized dose-response curve is then presented, introducing (±) amphetamine hydrochloride (0.01-1 mg mL

Indexed as

Molecularly Imprinted PolymersAmphetamineAmphetaminesBrompheniramineBupropionColoring AgentsDose-Response Relationship, DrugElectrochemical TechniquesFalse Positive ReactionsHumansIbuprofenLimit of DetectionMolecular ImprintingNaproxenPheniraminePiperidines1-(1-(2-methoxyphenyl)-2-phenylethyl)piperidineAmphetamineAmphetaminesBrompheniramineBupropionColoring AgentsIbuprofenMolecularly Imprinted PolymersNaproxenPheniraminePiperidinesPolymersPowdersQuetiapine Fumarateamphetaminecolorimetrydisplacement assaymolecularly imprinted polymers

Identifiers

PMID33182534
PMCPMC7696774
OpenAlexW3100549492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.